Rickettsial Pathogen Perturbs Tick Circadian Gene to Infect the Vertebrate Host
is a medically important tick that transmits several microbes to humans, including rickettsial pathogen . In nature, these ticks encounter several abiotic factors including changes in temperature, humidity, and light. Many organisms use endogenously generated circadian pathways to encounter abiotic...
Saved in:
Published in | International journal of molecular sciences Vol. 23; no. 7; p. 3545 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
24.03.2022
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | is a medically important tick that transmits several microbes to humans, including rickettsial pathogen
. In nature, these ticks encounter several abiotic factors including changes in temperature, humidity, and light. Many organisms use endogenously generated circadian pathways to encounter abiotic factors. In this study, we provide evidence for the first time to show that
modulates the arthropod circadian gene for its transmission to the vertebrate host. We noted a circadian oscillation in the expression of arthropod
,
,
and
genes when ticks or tick cells were exposed to alternate 12 h light: 12 h dark conditions. Moreover,
significantly modulates the oscillation pattern of expression of these genes. In addition, increased levels of
and
and decreased expression of Toll and JAK/STAT pathway immune genes such as
and
respectively, were noted during
transmission from ticks to the vertebrate host. RNAi-mediated knockdown of
gene expression in ticks resulted in the reduced expression of
and
that increased bacterial transmission from ticks to the murine host. Furthermore,
-deficient ticks fed late and had less engorgement weights. These results indicate an important role for circadian modulation of tick gene expression that is critical for arthropod blood feeding and transmission of pathogens from vector to the vertebrate host. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Current address: Gene Transfer and Immunogenicity Branch, Division of Cellular and Gene Therapies, CBER, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Current address: Viome Lifesciences Inc., Bothell, WA 98011, USA. Current address: Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA. |
ISSN: | 1422-0067 1661-6596 1422-0067 |
DOI: | 10.3390/ijms23073545 |